<DOC>
	<DOCNO>NCT00645398</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety pregabalin versus placebo symptomatic relief pain associate fibromyalgia . If objective met , second objective evaluate efficacy safety pregabalin versus placebo management fibromyalgia ( pain , patient global assessment , functional status ) . Additionally , study evaluate efficacy pregabalin versus placebo improve sleep , fatigue , mood disturbance associate fibromyalgia .</brief_summary>
	<brief_title>A Study Efficacy Safety Pregabalin Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients meet American College Rheumatology ( ACR ) criterion fibromyalgia ( ie , widespread pain present least 3 month , pain least 11 18 specific tender point site ) Patients complete least 4 pain diary within last 7 day average pain score must ≥4 , score ≥40 mm Visual Analogue Scale ( VAS ) SFMPQ screen ( Visit 1 ) randomization ( Visit 2 ) Patients severe pain may confound assessment selfevaluation pain associate fibromyalgia Patients inflammatory muscle rheumatologic disease fibromyalgia , active infection , untreated endocrine disorder Patients severe depression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>